Back
10x Genomics Falters on 39% Sales Drop, Scraps 2026 Outlook
Back
Stock News
Themes
10x Genomics Falters on 39% Sales Drop, Scraps 2026 Outlook
10x Genomics Falters on 39% Sales Drop, Scraps 2026 Outlook
Edgen Stock
·
Jan 20 2026, 10:15
Share to
Share to
Copy link
TXG
+4.89%
source:
[1] Weak Instrument Sales And No 2026 Outlook Could Be A Game Changer For 10x Genomics (TXG)
Recommend
Apple Stock Climbs as Investors Shun Big Tech's $650B AI Spending
Feb 18 2026, 00:32
Similarweb Swings to Profit, Beating Q4 Estimates
Feb 17 2026, 23:58
Hormel Sells Turkey Business, Reaffirms 2026 Guidance
Feb 17 2026, 23:57
Features
AI Copilot for Stock & Crypto
Price Prediction
Fundraise Tracker
Themes
Crypto Comparison
Home Page
Resources
Tutorial
Gitbook
Team
Aura Insights
Market
US Market
HK Market
Crypto Market
Terms of Use
Privacy Policy
Sitemap
© 2026 Finture Development Limited. All rights reserved
Edgen Stock·Jan 20 2026, 10:15Edgen Stock·Jan 20 2026, 10:15
Edgen Stock·Jan 20 2026, 10:15